Response to Platinum-based Neoadjuvant Chemotherapy in Cervical Cancer

Cancer 3 variants 0 genes

Upload your DNA to see your personal risk score for Response to Platinum-based Neoadjuvant Chemotherapy in Cervical Cancer.

Associated Variants (3)
RSID Gene Risk Allele Odds Ratio Evidence
RS6812281 — T 2.37 moderate
RS1364121 — A 1.98 moderate
RS1742101 — G 1.92 moderate
Sign Up to Analyze Your DNA Log In